Sinovac Biotech Ltd
SVA.O- Latest Trade
- trading higher6.47USD
- Change
- 0
- % Change
0.00%
- Day Range
- -- - --
- 52-Week Range
- 6.25 - 6.58
As of May 26 2022. Values delayed up to 15 minutes
- Previous Close
- 6.47
- Open
- 0.00
- Volume
- 0.00
- 3 Month Average Trading Volume
- 0.00
- Shares Out (Mil)
- 99.50
- Market Cap
- 639.90
- Forward P/E
- -99,999.99
- Dividend Yield
- -99,999.99
Key Statistics
mean rating - analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 0.03
- Price To Book (Quarterly)
- -99,999.99
- Price To Cash Flow (Per Share TTM)
- 0.04
- Total Debt/Total Equity (Quarterly)
- 0.24
- Long Term Debt/Equity (Quarterly)
- 0.19
- Return On Investment (TTM)
- 271.92
- Return On Equity (TTM)
- 155.06
2021 (millions USD)
About Sinovac Biotech Ltd
Company Information
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.
Address
39 Shangdi Xi Road, Haidian DistrictBEIJING, BEJ
102200
China
Industry
Biotechnology & Drugs
Executive Leadership
- WeiDong Yin
- Chairman of the Board, President, Chief Executive Officer, Secretary
- Nan Wang
- Chief Financial Officer, Vice President
- Qiang Gao
- Chief Operating Officer, Vice President
- Jing Li
- Vice President - Quality and Production
- Simon J. Anderson
- Independent Director
- Shan Fu
- Independent Director
- Kenneth Lee
- Independent Director
- Yuk Lam Lo
- Independent Director
- Meng Mei
- Independent Director
Latest News
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,841.10 | 0.28%Negative |
| Copper | 774.00 | 0.75%Negative |
| Brent Crude Oil | 114.54 | 0.45%Positive |
| CBOT Soybeans | 1,675.50 | 0.33%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,978.73 | -- |
| Euro STOXX 50 | 3,702.24 | 0.68%Positive |
| FTSE 100 | 7,527.75 | 0.07%Positive |
| Nikkei 225 | 26,604.84 | 0.27%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes